Establishment of Centrosome Amplification-Correlated Model to Evaluate the Tumor Immune Microenvironment and Prognosis of Patients with Glioblastoma.

Key Points

• The aim is to construct a centrosome amplification-related model to evaluate prognosis and the tumor immune microenvironment in glioblastoma patients.
• Developed a centrosome amplification-related model.
• Assessed prognosis in glioblastoma patients.
• Evaluated the tumor immune microenvironment (TIME) using this model.
• The model effectively correlates centrosome amplification with patient prognosis.
• Findings may assist in clinical decision-making for glioblastoma management.